EUVIMEDEUVIMED entdecken
Crossref

Long‐Term Efficacy of Intra‐Articular Platelet‐Rich Plasma in Knee Osteoarthritis: A 6‐Year Follow‐up of a Prospective Cohort

Mir Shahid Ul Islam, Altaf Hussain iD, Najmul Huda, Amit Saraf, Sandeep Bishnoi, Hemant Kumar

Journal of Orthopaedic Research · 2026

DOI: 10.1002/jor.70139 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Orthopaedic Research, 2026. Verfasst von Mir Shahid Ul Islam und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedic Surgery, Venkateshwara Institute of Medical Sciences, Gajraula, Uttar pradesh, India. Hauptthemen laut MEDLINE: Osteoarthritis, Knee, Platelet-Rich Plasma. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 34 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This prospective study evaluated the long‐term efficacy, radiographic progression, and predictors of deterioration in patients with knee osteoarthritis (KOA) treated with intra‐articular platelet‐rich plasma (PRP) injections. Seventy‐eight patients (118 knees) with Kellgren–Lawrence (KL) grade I–III KOA received 3 monthly PRP injections and were followed at 4 and 6 years. Pain and function were assessed with the Visual Analogue Scale (VAS) and Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC). Radiographic progression, analgesic use, and predictors of clinical worsening were analysed using linear mixed‐effects modeling and survival analysis. At 4 years, significant improvements were observed in VAS (6.72 ± 1.82 to 4.47 ± 1.32, p < 0.0001) and WOMAC (58.32 ± 17.58 to 39.67 ± 10.37, p < 0.0001). By 6 years, outcomes regressed toward baseline (VAS 6.31 ± 1.47, p = 0.079; WOMAC 56.45 ± 14.35, p = 0.41). Benefits were more sustained in KL I–II compared with KL III, who showed earlier decline and greater analgesic use. KL progression was the strongest predictor of worsening ( β = +14.2 WOMAC points, p < 0.001), with each baseline KL grade increase adding +6.5 WOMAC points ( p = 0.002); BMI also contributed modestly ( p = 0.018). Survival analysis showed KL III had a 3.1‐fold higher failure risk than KL I (median 3.5 vs. 5.1 years, p < 0.001). PRP provides meaningful symptom relief and functional improvement for up to 4 years in mild‐to‐moderate KOA, but benefits decline by 6 years, particularly in advanced disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Osteoarthritis, KneePlatelet-Rich PlasmaHumansFemaleMaleProspective StudiesInjections, Intra-ArticularMiddle AgedAgedFollow-Up StudiesTreatment OutcomeDisease ProgressionPain Measurement

Autor:innen und Institutionen

  • Department of Orthopaedic Surgery, Venkateshwara Institute of Medical Sciences, Gajraula, Uttar pradesh, India.
  • Department of Orthopaedic Surgery, Teerthanker Mahaveer Medical College and Research Centre, Moradabad, Uttar Pradesh, India.

ORCID-Profile: Altaf Hussain

Zitieren

APA

Islam, M. S. U., Hussain, A., Huda, N., Saraf, A., Bishnoi, S., & Kumar, H. (2026). Long‐Term Efficacy of Intra‐Articular Platelet‐Rich Plasma in Knee Osteoarthritis: A 6‐Year Follow‐up of a Prospective Cohort. Journal of Orthopaedic Research. https://doi.org/10.1002/jor.70139

Vancouver

Islam MSU, Hussain A, Huda N, Saraf A, Bishnoi S, Kumar H. Long‐Term Efficacy of Intra‐Articular Platelet‐Rich Plasma in Knee Osteoarthritis: A 6‐Year Follow‐up of a Prospective Cohort. Journal of Orthopaedic Research. 2026. doi:10.1002/jor.70139

BibTeX
@article{Islam2026,
  author = {Islam, Mir Shahid Ul and Hussain, Altaf and Huda, Najmul and Saraf, Amit and Bishnoi, Sandeep and Kumar, Hemant},
  title = {Long‐Term Efficacy of Intra‐Articular Platelet‐Rich Plasma in Knee Osteoarthritis: A 6‐Year Follow‐up of a Prospective Cohort},
  journal = {Journal of Orthopaedic Research},
  year = {2026},
  doi = {10.1002/jor.70139}
}
Kostenlos starten →